Table 1.
Systematic review/ meta-analysis |
Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Item 11 | Total score | |
Systematic reviews and meta-analysis involved patients with ACS | |||||||||||||
1 | Barth et al69 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 11 |
2 | Devi et al44 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA | Yes | 10 |
3 | Ghisi et al50 | CA | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | No | No | 7 |
4 | Kotb et al59 | CA | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | No | Yes | 8 |
5 | Brown et al37 | Yes | No | Yes | CA | No | Yes | Yes | Yes | Yes | NA | Yes | 7 |
6 | Dickens et al45 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
7 | Aldcroft et al31 | CA | No | Yes | CA | NO | Yes | Yes | Yes | Yes | No | Yes | 6 |
8 | Brown et al70 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA | Yes | 10 |
9 | Huttunen-Lenz et al56 | CA | No | Yes | CA | No | Yes | Yes | Yes | Yes | No | No | 5 |
10 | Goulding et al51 | Yes | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | No | Yes | 8 |
11 | Auer et al34 | CA | Yes | Yes | CA | No | No | Yes | No | Yes | Yes | No | 5 |
12 | Barth et al36 | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 10 |
13 | Fernandez et al48 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No | 8 |
14 | Barth et al35 | CA | Yes | Yes | CA | No | Yes | CA | Yes | Yes | Yes | Yes | 7 |
15 | Clark et al41 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
Systematic reviews and meta-analysis involved patients with T2DM | |||||||||||||
16 | Choi et al40 | CA | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
17 | Creamer et al42 | Yes | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | No | Yes | 8 |
18 | Huang et al55 | CA | CA | Yes | CA | No | Yes | Yes | Yes | Yes | Yes | Yes | 7 |
19 | Chen et al39 | CA | CA | Yes | CA | No | Yes | Yes | Yes | Yes | Yes | Yes | 7 |
20 | Pillay et al71 | Yes | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | 9 |
21 | Terranova et al72 | CA | CA | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
22 | Attridge et al33 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | 10 |
23 | Odnoletkova et al66 | Yes | CA | Yes | CA | No | No | Yes | Yes | Yes | Yes | No | 6 |
24 | Pal et al67 | CA | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | No | Yes | 8 |
25 | Ricci-Cabello et al73 | Yes | CA | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | 9 |
26 | Saffari et al74 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
27 | Gucciardi et al52 | CA | Yes | Yes | No | No | Yes | Yes | Yes | Yes | No | Yes | 7 |
28 | Pal et al68 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | 10 |
29 | van Vugt et al75 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | NA | No | Yes | 6 |
30 | Amaeshi32 | CA | CA | Yes | No | No | Yes | Yes | Yes | NA | No | No | 4 |
31 | Nam et al62 | CA | CA | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
32 | Steinsbekk et al76 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | No | Yes | 7 |
33 | Burke et al38 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NA | Yes | 10 |
34 | Lun Gan et al57 | Yes | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | No | Yes | 8 |
35 | Ramadas et al77 | CA | CA | Yes | No | No | Yes | Yes | Yes | NA | No | Yes | 5 |
36 | Hawthorne et al54 | Yes | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | CA | Yes | 8 |
37 | Minet et al61 | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | Yes | 9 |
38 | Alam et al30 | Yes | Yes | No | CA | No | Yes | Yes | Yes | Yes | Yes | Yes | 8 |
39 | Duke et al46 | Yes | CA | Yes | No | Yes | Yes | Yes | Yes | Yes | No | Yes | 8 |
40 | Fan and Sidani47 | Yes | No | Yes | CA | No | Yes | No | No | Yes | No | Yes | 5 |
41 | Hawthorne et al53 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 11 |
42 | Khunti et al58 | CA | Yes | Yes | Yes | No | Yes | No | No | No | No | Yes | 5 |
43 | Loveman et al60 | Yes | CA | Yes | Yes | No | Yes | Yes | Yes | Yes | No | Yes | 8 |
44 | Wens et al78 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | Yes | NA | Yes | 7 |
45 | Nield et al63 | Yes | Yes | Yes | CA | Yes | Yes | Yes | Yes | Yes | No | Yes | 9 |
46 | Zabaleta and Forbes79 | CA | CA | Yes | CA | Yes | Yes | Yes | Yes | NA | No | No | 5 |
47 | Deakin et al43 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 11 |
48 | Vermeire et al80 | Yes | Yes | Yes | CA | Yes | Yes | Yes | Yes | Yes | No | Yes | 9 |
49 | Gary et al49 | CA | Yes | No | Yes | No | Yes | Yes | No | Yes | No | Yes | 6 |
50 | Norris et al65 | CA | No | Yes | No | No | Yes | Yes | Yes | CA | No | No | 4 |
51 | Norris et al64 | CA | Yes | Yes | CA | No | Yes | Yes | Yes | NA | No | No | 5 |
Item 1: ‘Was an "a priori" design provided?’,Source:Shea et al22; Item 2: ‘Was there duplicate study selection and data extraction?’; Item 3: ‘Was a comprehensive literature search performed?’; Item 4: ‘Was the status of publication (ie, grey literature) used as an inclusion criterion?’; Item 5: ‘Was a list of studies (included and excluded) provided?’; Item 6: ‘Were the characteristics of the included studies provided?’; Item 7: ‘Was the scientific quality of the included studies assessed and documented?’; Item 8: ‘Was the scientific quality of the included studies used appropriately in formulating conclusions?’; Item 9: ‘Were the methods used to combine the findings of studies appropriate?’; Item 10: ‘Was the likelihood of publication bias assessed?’; Item 11: ‘Was the conflict of interest stated?’
CA, cannot answer; NA, not applicable.